Farther Finance Advisors’s Cardlytics CDLX Stock Holding History

Farther Finance Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12	Hold	4	–	–	﹤0.01%	6085
2026 Q2	$18	Hold	4	–	–	﹤0.01%	5907
2026 Q1	$40	Hold	4	–	–	﹤0.01%	5595
2025 Q4	$46	Hold	4	–	–	﹤0.01%	5356
2025 Q3	$97	Hold	4	–	–	﹤0.01%	4824
2025 Q2	$66	Hold	4	–	–	﹤0.01%	4350
2025 Q1	$76	Hold	4	–	–	﹤0.01%	4096
2024 Q4	$160	Hold	4	–	–	﹤0.01%	3704
2024 Q3	$138	Hold	4	–	–	﹤0.01%	3729
2024 Q2	$347	Hold	4	–	–	﹤0.01%	3360
2024 Q1	$622	Sell	4 -1	-20%	-$84	﹤0.01%	2949
2023 Q4	$424	Buy	+5	New	+$508	﹤0.01%	3019
2023 Q1	–	Sell	-7	Closed	-$422	–	2363
2022 Q4	$422	Buy	+7	New	+$432	﹤0.01%	1865

Farther Finance Advisors's CDLX Position: Q3 2026 in Review

Farther Finance Advisors held its Cardlytics (CDLX) position steady in Q3 2026 at 4 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #6085.

Farther Finance Advisors first reported a position in CDLX in Q4 2022 and has held it in 13 quarters since. The position peaked at $622 in Q1 2024. 1 fund tracked by Wall St. Rank holds CDLX as of Q3 2026.

Farther Finance Advisors held 4 shares of Cardlytics worth $12 as of Q3 2026.
Farther Finance Advisors left its Cardlytics share count unchanged in Q3 2026.
Cardlytics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6085 holding.
Farther Finance Advisors first reported a position in Cardlytics in Q4 2022 and has held it in 13 quarters since.
Farther Finance Advisors's Cardlytics position peaked at $622 in Q1 2024.
1 fund tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.